Ánita Lawitschka

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

Stephanie J. Lee, Daniel Wolff, Carrie L. Kitko et al. · Biology of Blood and Marrow Transplantation · 2015 · 402 citations · Full text

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease

Thomas Lion, Rosi Baumgartinger, Franz Watzinger et al. · Blood · 2003 · 361 citations

Real-Time Quantitative PCR Assays for Detection andMonitoring of Pathogenic Human Viruses in ImmunosuppressedPediatricPatients

Franz Watzinger, Magdalena Suda, Sandra Preuner et al. · Journal of Clinical Microbiology · 2004 · 330 citations · Full text

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

Daniel Wolff, Michael Schleuning, Stephanie von Harsdorf et al. · Biology of Blood and Marrow Transplantation · 2010 · 329 citations · Full text

Cell Therapy, Immunology, Biological Therapy +22

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

Tapani Ruutu, Aloïs Gratwohl, T. de Witte et al. · Bone Marrow Transplantation · 2013 · 303 citations

Medical Treatment, Preventive Medicine, Treatment And Prevention +7